Emphysema Diagnosis and Evaluation

Pulmonology focuses on diagnosing and treating lung and airway conditions such as asthma, COPD, and pneumonia, as well as overall respiratory health.

Emphysema diagnosis requires more than noticing shortness of breath. The doctor needs to understand whether the lungs have lost elasticity, whether air is trapped, and how much gas exchange is affected.

Symptoms such as breathlessness, chest tightness, wheezing, fatigue, or reduced exercise capacity may suggest emphysema, but testing is needed for a clearer diagnosis.

Patients who want to review early warning signs can visit the Emphysema Symptoms and Risk Factors section.

At Liv Hospital, pulmonology specialists evaluate symptoms, smoking or exposure history, lung function, oxygen level, CT findings, and daily activity capacity together.

Physical examination gives the first clues about hyperinflation and airflow limitation. It helps the doctor decide which tests are needed next.

During examination, the doctor may check for:

• Barrel-shaped chest
• Pursed-lip breathing
• Use of neck or shoulder muscles
• Reduced breath sounds
• Wheezing during exhalation
• Hyperresonance during chest percussion
• Distant heart sounds
• Bluish lips or fingertips
• Signs of breathing effort

Digital clubbing is not typical in uncomplicated emphysema. If it is present, the doctor may look for another condition such as lung cancer, bronchiectasis, or chronic infection.

For a clearer explanation of how alveolar damage causes these findings, patients can visit the Emphysema Overview and Definition section.

Spirometry is one of the main tests used in emphysema evaluation. It measures how much air a patient can breathe out and how quickly the air leaves the lungs.

The test may assess:

• FEV1
• FVC
• FEV1/FVC ratio
• Airflow obstruction
• Disease severity
• Bronchodilator response
• Flow-volume loop pattern
• Change compared with previous tests

In emphysema, airflow may be reduced because small airways collapse during exhalation.

A low FEV1/FVC ratio can support the diagnosis of obstructive lung disease. The result is interpreted together with symptoms, exposure history, and imaging.

Spirometry shows airflow, but lung volume testing shows how much air remains trapped inside the lungs.

Body plethysmography, also known as the body box test, can measure hyperinflation more clearly.

Lung volume testing may evaluate:

• Total lung capacity
• Residual volume
• Functional residual capacity
• RV/TLC ratio
• Severity of air trapping
• Impact on breathing effort
• Hyperinflation level during rest
• Need for further functional assessment

In emphysema, residual volume may increase because the patient cannot fully empty the lungs.

This trapped air can make the diaphragm work less efficiently and increase breathlessness during activity.

DLCO measures how well oxygen moves from the air sacs into the blood. This is important because emphysema damages the alveolar surface used for gas exchange.

A low DLCO may show that the lung’s oxygen transfer capacity is reduced.

DLCO testing may help assess:

• Alveolar-capillary damage
• Gas exchange efficiency
• Exercise-related breathlessness
• Oxygen transfer problems
• Need for oxygen assessment
• Difference between emphysema and chronic bronchitis
• Functional impact of lung tissue destruction

This test can help separate emphysema from asthma or chronic bronchitis when symptoms overlap.

At Liv Hospital, DLCO results are reviewed with spirometry, CT imaging, oxygen saturation, and daily activity symptoms.

High-resolution CT gives detailed images of lung tissue. It can show emphysema more clearly than a standard chest X-ray, especially in early or complex cases.

CT imaging may help identify:

• Areas of destroyed lung tissue
• Centrilobular emphysema
• Panlobular emphysema
• Paraseptal emphysema
• Bullae
• Air trapping pattern
• Lung nodules in selected patients
• Other structural lung diseases

CT can also help doctors understand whether emphysema is linked more strongly with smoking, alpha-1 antitrypsin deficiency, or another pattern.

Patients who want to understand how test results guide care can visit the Emphysema Treatment and Management section.

Alpha-1 antitrypsin deficiency is a genetic condition that can increase emphysema risk. Testing may be considered when emphysema appears at a younger age, develops in a non-smoker, or progresses faster than expected.

Evaluation may include:

• Alpha-1 antitrypsin blood level
• Genetic testing when needed
• Family risk discussion
• Liver health review in selected patients
• Smoking history assessment
• Long-term monitoring plan

Identifying this condition can change follow-up planning. It may also help family members understand whether they should seek medical advice.

At Liv Hospital, genetic risk is reviewed when the clinical pattern suggests inherited susceptibility.

Arterial blood gas analysis may be needed in advanced emphysema or when oxygen levels are low.

This test measures oxygen, carbon dioxide, and blood acidity.

ABG may help evaluate:

• Hypoxemia
• Carbon dioxide level
• Acid-base balance
• Respiratory failure risk
• Need for oxygen therapy
• Safety before procedures
• Severity during flare-ups
• Need for closer monitoring

Not every patient needs this test. It is usually selected when symptoms, oxygen saturation, or disease severity suggest a more advanced problem.

ABG results are interpreted together with lung function, imaging, and clinical findings.

The 6-minute walk test helps show how emphysema affects real-life activity. Some patients have acceptable oxygen levels at rest but drop during movement.

During the test, the patient walks for six minutes while distance and oxygen saturation are monitored.

This test may assess:

• Walking capacity
• Exercise-related oxygen drop
• Breathlessness during activity
• Need for ambulatory oxygen
• Rehabilitation baseline
• Functional limitation
• Response to treatment over time

The result helps the doctor understand how emphysema affects daily movement, not only laboratory values.

Patients who want to learn about long-term activity planning can visit the Emphysema Recovery and Prevention section.

Emphysema can place stress on the heart, especially when oxygen levels are low or pulmonary blood vessels are affected.

Echocardiography may be used to evaluate heart function and screen for pulmonary hypertension or right-heart strain.

Heart assessment may review:

• Pulmonary artery pressure
• Right heart size
• Right heart function
• Valve function
• Fluid overload signs
• Breathlessness related to heart disease
• Overall treatment risk

This step is important because breathlessness may come from both lung and heart problems.

At Liv Hospital, pulmonology and related specialties can coordinate care when emphysema affects more than the lungs.

Emphysema diagnosis should be detailed, objective, and personalized. Liv Hospital supports patients with pulmonology expertise, spirometry, lung volume measurement, DLCO, CT imaging, oxygen assessment, alpha-1 antitrypsin evaluation, exercise testing, and heart assessment.

For international patients, Liv Hospital can assist with appointment planning, communication support, diagnostic coordination, second opinion evaluation, treatment review, and follow-up guidance.

If breathlessness, reduced exercise capacity, wheezing, chest tightness, or previous abnormal imaging affects daily life, Liv Hospital Pulmonology Department can guide the next step.

Emphysema should be evaluated with the right tests before breathing limitation becomes harder to manage.

Contact Liv Hospital to discuss your symptoms, review previous lung tests or CT results, and receive personalized guidance from pulmonology specialists.